A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40m
This study has been completed.
Study NCT00464308.
Last updated on April 16, 2009.
Information provided by Janssen-Cilag Pty Ltd
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
